These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 153004)

  • 1. Our fibrinolytic potential.
    Villavicencio L
    Surgery; 1979 Jan; 85(1):53-8. PubMed ID: 153004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular fibrinolysis of small-vessel thrombosis.
    Cooney WP; Wilson MR; Wood MB
    J Hand Surg Am; 1983 Mar; 8(2):131-8. PubMed ID: 6220052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of human fibrinolysin by aerosol in the treatment of the pulmonary hyaline membrane syndrome. Studies on the fibrinolytic system of normal premature babies and older children.
    VILLAVICENCIO JL; JURADO E; SAGAON J; ALVAREZ DE LOS COBOS J
    Surg Forum; 1960; 11():8-10. PubMed ID: 13781423
    [No Abstract]   [Full Text] [Related]  

  • 4. Cross-species pharmacologic evaluation of plasmin as a direct-acting thrombolytic agent: ex vivo evaluation for large animal model development.
    Landskroner K; Olson N; Jesmok G
    J Vasc Interv Radiol; 2005 Mar; 16(3):369-77. PubMed ID: 15758133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Importance of the fibrinogen-heparin complex in the fibrinolytic activity of the blood euglobulin fraction after the intravenous administration of thrombin or plasmin].
    Kudriashov BA; Liapina LA; Ul'ianov AM
    Vopr Med Khim; 1978; 24(2):255-60. PubMed ID: 149422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of peritoneal adhesions in the rat. The effects of dexamethasone, methylprednisolone, promethazine, and human fibrinolysin.
    Gazzaniga AB; James JM; Shobe JB; Oppenheim EB
    Arch Surg; 1975 Apr; 110(4):429-32. PubMed ID: 125075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow system.
    Bizjak N; Bajd F; Vidmar J; Blinc A; Perme MP; Marder VJ; Novokhatny V; Serša I
    Thromb Res; 2014 May; 133(5):908-13. PubMed ID: 24613694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis].
    Kudinov SA; Kolesnik LA; Makogonenko EM; Shuliakovskaia TA
    Biokhimiia; 1989 Nov; 54(11):1881-7. PubMed ID: 2534055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New theory of fibrinolytic mechanism in the development of hyaline membrane disease in newborn infants].
    Uszyńska-Folejewska R; Uszyński M
    Pediatr Pol; 1975 Dec; 50(12):1513-5. PubMed ID: 127976
    [No Abstract]   [Full Text] [Related]  

  • 10. Cleavage of surfactant-incorporating fibrin by different fibrinolytic agents. Kinetics of lysis and rescue of surface activity.
    Günther A; Markart P; Kalinowski M; Ruppert C; Grimminger F; Seeger W
    Am J Respir Cell Mol Biol; 1999 Dec; 21(6):738-45. PubMed ID: 10572071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on hyaine membrane disease.3. Thrapeutic trial of urokinase-activated huma plasmin.
    Ambrus CM; Weintrb DH; Ambrus JL
    Pediatrics; 1966 Aug; 38(2):231-43. PubMed ID: 4223366
    [No Abstract]   [Full Text] [Related]  

  • 12. Can a pro-coagulant substance prevent adhesions?
    Elkins TE
    Prog Clin Biol Res; 1990; 358():103-12. PubMed ID: 2217486
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of free fatty acids on fibrinolytic activity.
    Muraoka T; Okuda H
    J Biochem; 1977 Aug; 82(2):529-33. PubMed ID: 144117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport phenomena and clot dissolving therapy: an experimental investigation of diffusion-controlled and permeation-enhanced fibrinolysis.
    Wu JH; Siddiqui K; Diamond SL
    Thromb Haemost; 1994 Jul; 72(1):105-12. PubMed ID: 7974357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A method for determining plasmin by the rate of fibrin gel lysis].
    Popova GIu; Eremeev NL; Aĭsina RB; Kazanskaia NF
    Biull Eksp Biol Med; 1989 May; 107(5):561-4. PubMed ID: 2525408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation and properties of acylplasmin].
    Aĭsina RB; Kazanskaia NF; Andreenko GV; Liutova LV; Pén'ia K
    Vopr Med Khim; 1985; 31(4):30-4. PubMed ID: 2931900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.
    Summaria L; Sandesara J; Yang G; Vagher JP; Caprini JA
    Thromb Haemost; 1986 Aug; 56(1):71-9. PubMed ID: 2946093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of heparin and a covalently-linked antithrombin-heparin complex with components of the fibrinolytic system.
    Chander A; Atkinson HM; Stevic I; Berry LR; Kim PY; Chan AK
    Thromb Haemost; 2013 Dec; 110(6):1180-8. PubMed ID: 24048327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
    Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.